| |
|
Egg
(Oocyte) Freezing Clinical Study Now Available
What is this egg freezing study about?
In the last few years significant
interest in the benefits of human unfertilized oocytes
(egg) freezing has
emerged.
Essentially, potential benefits
could be:
- Assisting in and reducing the
cost of oocyte, egg,
donation,
- Providing egg storage for women
about to undergo therapy harmful to their reproductive
health (for example, chemotherapy for cancer patients).
- Those wishing to delay their
reproductive choices.
Because this technology is still
experimental, we at HRC have initiated a clinical study
in which we hope to develop this technology for practice.
At present most attempts at cryopreservation achieve a
50% survival rate, however this statistic is arrived at
by a 90-100% survival in one case and 0-10% in the next!
Consequently, different types of protocols may provide
the answer to increased consistent success. We believe
that cryopreservation of oocytes can be as reliable as
existing techniques of cryopreservation of embryos and
can improve the chance of pregnancy in certain patients.
What does egg freezing involve?
If you chose to participate in
this exciting clinical study, about 1/3 of your oocytes
will be frozen as part of your procedure to investigate
the technique. These will not be lost. They will be
returned to the uterus, if appropriate, at the time
of your embryo transfer.
How can this help me?
For your participation in the egg
freezing, we will be able to cover your medication expenses
and offer you a discount for your IVF cycle.
Who may participate?
Females under 35 years of age
with normal E2 and FSH levels, who are undergoing
standard infertility treatment by IVF and Intracytoplasmic
Sperm Injection (ICSI). Female’s response to
the medication must yield at least 10 eggs.
How do I sign up?
You may participate in this egg
freezing study at our 5 locations - (Fullerton,
Laguna
Hills, Pasadena,
Westlake
Village, and Tarzana).
Please contact the office site closest to you for more
details.
This clinical trial is supported
in part by an unrestricted education grant from Organon
Pharmaceuticals, Inc.
Additional Articles on Age and
Infertility
|
